Savaysa Drug Interactions
Currently displaying a list of 265 drugs known to interact with Savaysa (edoxaban).
- 162 major drug interactions
- 97 moderate drug interactions
- 6 minor drug interactions
Medications known to interact with Savaysa
Note: Showing generic names only.
A
- abciximab
- abiraterone
- abrocitinib
- acalabrutinib
- adagrasib
- ado-trastuzumab emtansine
- alemtuzumab
- alpelisib
- alteplase
- amiodarone
- anacaulase topical
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apalutamide
- apixaban
- ardeparin
- argatroban
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- atazanavir
- avacopan
- avapritinib
- azithromycin
B
- bepridil
- berotralstat
- betrixaban
- bismuth subsalicylate
- bivalirudin
- boceprevir
- brigatinib
- bromfenac
- bromfenac ophthalmic
C
- cabozantinib
- calaspargase pegol
- cangrelor
- caplacizumab
- capmatinib
- capsicum
- carbamazepine
- carvedilol
- celecoxib
- chamomile
- choline salicylate
- cilostazol
- citalopram
- clarithromycin
- clomipramine
- clopidogrel
- clove
- coagulation factor x
- cobicistat
- collagenase clostridium histolyticum
- conivaptan
- crizotinib
- cyclosporine
D
- dabigatran
- daclatasvir
- dalteparin
- danaparoid
- danicopan
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- diltiazem
- dipyridamole
- dong quai
- dronedarone
- drotrecogin alfa
- duloxetine
E
- elacestrant
- elagolix
- eliglustat
- encorafenib
- enoxaparin
- enzalutamide
- epoprostenol
- eptifibatide
- erdafitinib
- erythromycin
- escitalopram
- etodolac
- evening primrose
- ezogabine
F
- fedratinib
- felodipine
- fenfluramine
- fenoprofen
- fenugreek
- feverfew
- flibanserin
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- fosphenytoin
- fostamatinib
- futibatinib
G
H
I
- ibritumomab
- ibrutinib
- ibuprofen
- icosapent
- iloprost
- indomethacin
- inotersen
- iodine i 131 tositumomab
- ipilimumab
- isavuconazonium
- itraconazole
- ivacaftor
- ivosidenib
K
L
- lapatinib
- lasmiditan
- lecanemab
- lenacapavir
- lepirudin
- levoketoconazole
- levomilnacipran
- lomitapide
- lonafarnib
- lorlatinib
M
- magnesium salicylate
- meclofenamate
- mefenamic acid
- meloxicam
- mibefradil
- midostaurin
- mifepristone
- milnacipran
- mitapivat
N
O
P
- pacritinib
- panobinostat
- paroxetine
- pegaspargase
- pemigatinib
- pentosan polysulfate sodium
- pentoxifylline
- phenobarbital
- phenylbutazone
- phenytoin
- piroxicam
- pirtobrutinib
- pitolisant
- plasminogen, human
- plicamycin
- ponatinib
- pralsetinib
- prasugrel
- primidone
- progesterone
- protein c
Q
R
- ramucirumab
- ranolazine
- regorafenib
- reteplase
- rifampin
- ripretinib
- ritonavir
- rivaroxaban
- rofecoxib
- rolapitant
- ruxolitinib
S
- salsalate
- saquinavir
- sarecycline
- selpercatinib
- selumetinib
- sertraline
- sibutramine
- simeprevir
- sodium iodide i-123
- sodium iodide-i-131
- sodium salicylate
- sodium thiosalicylate
- sorafenib
- sotorasib
- sparsentan
- spironolactone
- st. john's wort
- streptokinase
- sugammadex
- sulfinpyrazone
- sulindac
- sunitinib
- suprofen ophthalmic
- suvorexant
T
- tacrolimus
- tafasitamab
- tamoxifen
- tazemetostat
- telaprevir
- telithromycin
- temsirolimus
- tenecteplase
- tepotinib
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tolvaptan
- tositumomab
- treprostinil
- tucatinib
- turmeric
U
V
- valdecoxib
- vemurafenib
- venetoclax
- venlafaxine
- verapamil
- verteporfin
- vilazodone
- vitamin e
- voclosporin
- vorapaxar
- vortioxetine
W
Z
Savaysa disease interactions
There are 5 disease interactions with Savaysa (edoxaban) which include:
More about Savaysa (edoxaban)
- Savaysa consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: factor Xa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.